ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2015, Vol. 7 ›› Issue (6): 611-613.doi: 10.3969/j.issn.1674-3865.2015.06.028

• 教学研究 • 上一篇    下一篇

孟鲁司特钠治疗小儿急性上呼吸道感染后喘息的作用

郭艳辉,王秋华,李孟   

  1. 511495 广州,广州中医药大学祈福医院儿科
  • 出版日期:2015-12-25 发布日期:2018-11-19
  • 通讯作者: 郭艳辉,E-mail:412686578@qq.com
  • 作者简介:郭艳辉(1980-),女,主治医师。研究方向:儿童疾病的诊断与治疗

Effect of montelukast sodium on wheezing in children with acute upper respiratory tract infection

GUO Yanhui, WANG Qiuhua, LI Meng   

  1. Qi Fu Hospital of Guangzhou Traditional Chinese Medicine University, Guangzhou 511495,China
  • Online:2015-12-25 Published:2018-11-19

摘要:
目的: 观察孟鲁司特钠对小儿急性上呼吸道感染后喘息的预防作用。
方法: 2013-09/2014-08广州中医药大学祈福医院儿科收治1~3岁既往有2次或以上喘息的急性上呼吸道感染患儿126例,随机分为两组,观察组66例,对照组60例。在予对症治疗基础上,观察组于急性上呼吸道感染发病24 h内予口服孟鲁司特钠4 mg,每日1次,连服10 d,对照组则于急性上呼吸道感染出现喘息后予口服孟鲁司特钠片4 mg,每日1次,连服10 d。停药3个月后再次出现符合诊断标准的急性上呼吸道感染则根据交叉原则进行交叉对照。观察两组出现喘息的例数及重度喘息的例数。
结果: 观察组发生喘息的例数及重度喘息的例数于交叉前均较对照组明显减少,于交叉后则均较对照组明显增多。
结论: 孟鲁司特钠对1~3岁小儿急性上呼吸道感染后喘息有预防作用,早期应用可减少喘息发作的机会及减轻发作的程度。

关键词: 急性上呼吸道感染, 喘息, 孟鲁司特钠, 治疗应用, 儿童

Abstract:
Objective:To observe the prevention effect of montelukast sodium on wheezing in children with acute upper respiratory tract infection.
Methods:Totally 126 cases of children of 1-to 3-year-old with previously wheezing attack for more than two times after acute upper respiratory tract infection were divided into two groups: 66 cases for A group, 60 cases for B group. After basic symptomatic treatment, children in A group were treated with oral montelukast sodium at 4 mg once daily within 24 hours after the disease attack, and the treatment lasted for 10 days. Children in B group were treated with oral montelukast sodium at 4 mg once daily after the appearance of wheezing symptom, and the treatment also lasted for 10 days. According to crossover principle, we performed cross comparison of the two groups if children were diagnosed with acute upper respiratory tract infection again 3 months after stopping taking montelukast sodium. The cases of wheezing were observed and recorded.
Results:The number of children in A group with wheezing and serious wheezing was lower than that in B group before cross comparison. However, after cross comparison, the number of children with wheezing and serious wheezing in A group was higher than that in B group.
Conclusion:Montelukast sodium has preventive effect on wheezing in children between 1- to 3-year-old with acute upper respiratory tract infection. Early application can reduce the rate of wheezing attack and alleviate the severity.

Key words: Acute upper respiratory tract infection, Wheezing, Montelukast sodium, treatment application, Children